TCL Archive Groups Accepting Need for More Collaboration, NCI Backs Away From Drastic Structural Changes July 11, 1986
TCL Archive Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited May 28, 1976
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive ACCC T Discuss Personnel, Fund Sources, Clinical Research At Annual Meeting January 9, 1976